The role of B7-H4 on drug sensitivity of renal cancer cells was studied by measuring cell proliferation of B7-H4-silenced (siB7-H4) and non-specific-silenced (siNS) control cells upon treatment with targeted therapy. This evidence concerns the gene VTCN1 and renal carcinoma.